Allan M Andersen1, Philip T Ryan1, Fredrick X Gibbons2, Ronald L Simons3, Jeffrey D Long1,4, Robert A Philibert1,5,6. 1. 1 Department of Psychiatry, University of Iowa, Iowa City, IA, USA 52242. 2. 2 Department of Psychological Sciences, University of Connecticut, Storrs, CT 06269. 3. 3 Department of Sociology, University of Georgia, Athens, GA 30602. 4. 4 Department of Biostatistics, University of Iowa, Iowa City, IA USA 52242. 5. 5 Department of Biomedical Engineering, University of Iowa, Iowa City, IA, USA 52242. 6. 6 Behavioral Diagnostics, Coralville IA 52241.
Abstract
OBJECTIVES: -Determine whether an epigenetic assay for smoking predicts all-cause mortality in adults participating in a longitudinal study of Iowa adoptees. BACKGROUND: -Improved biomarkers for smoking are needed given its large public health impact and significant limitations of both self-report and current biomarkers, such as cotinine in detecting smoking. In the past 5 years, multiple epigenome-wide association studies of smoking have identified loci suitable for translation as epigenetic biomarkers for smoking, in particular the CpG cg05575921. Digital polymerase chain reaction methods hold promise for the development of this and other epigenetic biomarkers. METHODS: -Participants in the Iowa Adoption Studies were interviewed regarding their smoking habits. DNA was prepared from whole blood and bisulfite-converted for methylation analysis and digital droplet polymerase chain reaction assay of methylation at cg05575921 was performed. National Death Index records were requested for 584 study participants, resulting in 24 complete matches, 210 partial matches and 350 non-matching records. Complete matches were coded as deceased while the remainder were coded as alive (ie, censored). In total, methylation data and vital status information were available for a total of N = 193 subjects, including 15 deceased and 178 non-deceased. Cox regression was used to examine the ability of cg05575921 methylation as a continuous value to predict the timing of mortality with and without the inclusion of age, sex, race, BMI, marital status, educational status, socioeconomic status, cardiovascular risk factors, and a history of cancer as covariates. RESULTS: -Methylation at cg05575921 predicted the hazard of mortality as the sole predictor and after accounting for major demographic and clinical risk factors. The fitted model showed the hazard ratio increased by 3.5% for every 1% decrease in methylation. CONCLUSIONS: -Decreased methylation at cg05575921, an emerging epigenetic biomarker for smoking, was associated with early mortality in a longitudinal study of adults after accounting for the impact of major demographic and clinical risk factors for all-cause mortality. This approach may be useful in clinical research or actuarial assessments.
OBJECTIVES: -Determine whether an epigenetic assay for smoking predicts all-cause mortality in adults participating in a longitudinal study of Iowa adoptees. BACKGROUND: -Improved biomarkers for smoking are needed given its large public health impact and significant limitations of both self-report and current biomarkers, such as cotinine in detecting smoking. In the past 5 years, multiple epigenome-wide association studies of smoking have identified loci suitable for translation as epigenetic biomarkers for smoking, in particular the CpG cg05575921. Digital polymerase chain reaction methods hold promise for the development of this and other epigenetic biomarkers. METHODS: -Participants in the Iowa Adoption Studies were interviewed regarding their smoking habits. DNA was prepared from whole blood and bisulfite-converted for methylation analysis and digital droplet polymerase chain reaction assay of methylation at cg05575921 was performed. National Death Index records were requested for 584 study participants, resulting in 24 complete matches, 210 partial matches and 350 non-matching records. Complete matches were coded as deceased while the remainder were coded as alive (ie, censored). In total, methylation data and vital status information were available for a total of N = 193 subjects, including 15 deceased and 178 non-deceased. Cox regression was used to examine the ability of cg05575921 methylation as a continuous value to predict the timing of mortality with and without the inclusion of age, sex, race, BMI, marital status, educational status, socioeconomic status, cardiovascular risk factors, and a history of cancer as covariates. RESULTS: -Methylation at cg05575921 predicted the hazard of mortality as the sole predictor and after accounting for major demographic and clinical risk factors. The fitted model showed the hazard ratio increased by 3.5% for every 1% decrease in methylation. CONCLUSIONS: -Decreased methylation at cg05575921, an emerging epigenetic biomarker for smoking, was associated with early mortality in a longitudinal study of adults after accounting for the impact of major demographic and clinical risk factors for all-cause mortality. This approach may be useful in clinical research or actuarial assessments.
Entities:
Keywords:
Biomarkers; addiction; epigenetics; substance use disorders; tobacco
Authors: M Frommer; L E McDonald; D S Millar; C M Collis; F Watt; G W Grigg; P L Molloy; C L Paul Journal: Proc Natl Acad Sci U S A Date: 1992-03-01 Impact factor: 11.205
Authors: Ana Florescu; Roberta Ferrence; Tom Einarson; Peter Selby; Offie Soldin; Gideon Koren Journal: Ther Drug Monit Date: 2009-02 Impact factor: 3.681
Authors: Robert A Philibert; Jeffrey M Plume; Frederick X Gibbons; Gene H Brody; Steven R H Beach Journal: Front Genet Date: 2012-04-10 Impact factor: 4.599
Authors: Robert Philibert; Nancy Hollenbeck; Eleanor Andersen; Terry Osborn; Meg Gerrard; Frederick X Gibbons; Kai Wang Journal: Front Psychol Date: 2015-06-02
Authors: Marco P Boks; Eske M Derks; Daniel J Weisenberger; Erik Strengman; Esther Janson; Iris E Sommer; René S Kahn; Roel A Ophoff Journal: PLoS One Date: 2009-08-26 Impact factor: 3.240
Authors: Lene Christiansen; Adam Lenart; Qihua Tan; James W Vaupel; Abraham Aviv; Matt McGue; Kaare Christensen Journal: Aging Cell Date: 2015-11-17 Impact factor: 9.304
Authors: Francesca Fasanelli; Laura Baglietto; Erica Ponzi; Florence Guida; Gianluca Campanella; Mattias Johansson; Kjell Grankvist; Mikael Johansson; Manuela Bianca Assumma; Alessio Naccarati; Marc Chadeau-Hyam; Ugo Ala; Christian Faltus; Rudolf Kaaks; Angela Risch; Bianca De Stavola; Allison Hodge; Graham G Giles; Melissa C Southey; Caroline L Relton; Philip C Haycock; Eiliv Lund; Silvia Polidoro; Torkjel M Sandanger; Gianluca Severi; Paolo Vineis Journal: Nat Commun Date: 2015-12-15 Impact factor: 14.919